SQZ Biotechnologies Gross Margin 2020-2023 | SQZ
Current and historical gross margin for SQZ Biotechnologies (SQZ) over the last 10 years. The current gross profit margin for SQZ Biotechnologies as of March 31, 2023 is %.
| SQZ Biotechnologies Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2022-12-31 |
$0.02B |
$0.02B |
100.00% |
| 2022-09-30 |
$0.02B |
$0.02B |
100.00% |
| 2022-06-30 |
$0.02B |
$0.02B |
100.00% |
| 2022-03-31 |
$0.03B |
$0.03B |
100.00% |
| 2021-12-31 |
$0.03B |
$0.03B |
100.00% |
| 2021-09-30 |
$0.02B |
$0.02B |
100.00% |
| 2021-06-30 |
$0.02B |
$0.02B |
100.00% |
| 2021-03-31 |
$0.02B |
$0.02B |
100.00% |
| 2020-12-31 |
$0.02B |
$0.02B |
100.00% |
| 2020-06-30 |
$0.02B |
$0.02B |
100.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.016B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
